Jeanne Cook-Moreau
Overview
Explore the profile of Jeanne Cook-Moreau including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
302
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Denis-Lagache N, Oblet C, Marchiol T, Baylet A, Teteau O, Dalloul I, et al.
Front Immunol
. 2023 Jun;
14:1155906.
PMID: 37359540
Introduction: In mature B cells, activation-induced deaminase reshapes Ig genes through somatic hypermutation and class switch recombination of the Ig heavy chain () locus under control of its 3' -regulatory...
2.
Bruzeau C, Cook-Moreau J, Pinaud E, Le Noir S
Front Immunol
. 2022 Jul;
13:877930.
PMID: 35812441
B cells undergo genetic rearrangements at immunoglobulin gene () loci during B cell maturation. First recombination occurs during early B cell stages followed by class switch recombination (CSR) and somatic...
3.
Ferrad M, Ghazzaui N, Issaoui H, Drouineau E, Oblet C, Marchiol T, et al.
Leuk Lymphoma
. 2022 Apr;
63(9):2114-2125.
PMID: 35481805
The 3' regulatory region (3'RR) located downstream from the Cα gene is the conductor of transcription, accessibility, and remodeling of the IgH locus at mature B-cell stages. Convincing demonstrations of...
4.
Ferrad M, Ghazzaui N, Issaoui H, Marchiol T, Cook-Moreau J, Denizot Y
Immunol Lett
. 2021 Oct;
240:12-14.
PMID: 34599945
No abstract available.
5.
Ghazzaui N, Ferrad M, Issaoui H, Lecardeur S, Cook-Moreau J, Pollet J, et al.
Leuk Lymphoma
. 2021 Aug;
62(14):3511-3515.
PMID: 34429004
No abstract available.
6.
Dalloul Z, Best M, Chenuet P, Dalloul I, Le Noir S, Togbe D, et al.
Clin Transl Immunology
. 2021 Jun;
10(6):e1280.
PMID: 34136216
Objectives: Inhibitors of bromodomain and extra terminal domain (BET) proteins are a new and growing class of anti-cancer drugs, which decrease oncogene expression by targeting superenhancers. Antibody production is another...
7.
Ghazzaui N, Issaoui H, Martin O, Saintamand A, Cook-Moreau J, Denizot Y, et al.
Cell Mol Immunol
. 2021 Jun;
18(8):2081.
PMID: 34112966
No abstract available.
8.
Ferrad M, Ghazzaui N, Issaoui H, Cook-Moreau J, Denizot Y
Front Immunol
. 2020 Aug;
11:1564.
PMID: 32793219
Chromosomal translocations linking various oncogenes to transcriptional enhancers of the immunoglobulin heavy chain (IgH) locus are often implicated as the cause of B-cell malignancies. Two major IgH transcriptional enhancers have...
9.
Ghazzaui N, Issaoui H, Ferrad M, Carrion C, Cook-Moreau J, Denizot Y, et al.
Blood Adv
. 2020 Jan;
4(1):28-39.
PMID: 31899800
Numerous B-cell lymphomas feature translocations linking oncogenes to different locations in the immunoglobulin heavy chain (IgH) locus. During Burkitt lymphoma (BL), IgH breakpoints for c-myc translocation stand either close to...
10.
Issaoui H, Ferrad M, Ghazzaui N, Lecardeur S, Cook-Moreau J, Boyer F, et al.
Cell Mol Immunol
. 2019 Oct;
17(4):418-420.
PMID: 31595054
No abstract available.